Article and Video CATEGORIES
Dr. Jack West asks the question of whether newer, more active ALK inhibitors such as alectinib should be used as first line therapy rather than for acquired resistance, including introducing the ALEX trial that is trying to answer this question.
November is Lung Cancer Awareness Month. What are you grateful for?
Watch, read, and then share your own stories of empowerment in our online forum. Your story may inspire others.
[powerpress]
Get more information about the ALEX Trial.
[ratingwidget post_id=0]
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi Stan, It's good to hear your voice and know your cheesecakes are still making the rounds. Though I'm sure startling, I imagine some of those little pockets of the house...
Hi Rutbats, Welcome to GRACE and thanks for the kind words.
We can't say what you should or shouldn't do and I can't say why your RA doc made their...
Thank you very much for your quick answer, Janine.
I have an appointment with a pulmonologist in 10 days. I will summarize the conversation with him here, so that other people...
Glad to know you're moving forward with a pulmonologist. The more you know the better the conversation with your pulmonologist. Remember you can help your docs know what level their conversation...
Hi Terry, Welcome to Grace.
I saw this exact post somewhere else months back and the only response was to a lab. I hope that doesn't happen here, we don't allow...
Stan - Thank you once again for your kind words. Thank you as well for your donation. As you know, your donation helps us to exist and continue to fulfill our...